cSens


Public lists: Pharma Startups (4733)

cSens is a diagnostics company that has developed a PCR-based platform for the analysis of serum thymidine kinase (TK) enzyme activity, which correspond to tumor proliferation and cancer aggressiveness. In addition to the ability to measure TK clinically, the cSens diagnostic platform creates opportunities to expand pre-clinical measurements in cancer cell cultures and animal models. The platform can also be used to develop new biomarker assays and tests for other forms of cancer and novel drugs...Show all

cSens is a diagnostics company that has developed a PCR-based platform for the analysis of serum thymidine kinase (TK) enzyme activity, which correspond to tumor proliferation and cancer aggressiveness. In addition to the ability to measure TK clinic...Show all

Company (Acquired)

Phone:

Fax:




Sweden

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
cSens $0M May 17, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related cSens Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Kit and method May 13, 2011 Aug 30, 2016 Patent